
Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
Check price for EmbodyOn Embody's site · partner link
Comparison · updated October 27, 2026
Start with Embody if you want the smaller verified initial commitment.

Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
Check price for EmbodyOn Embody's site · partner link

Monthly plan · confirm the full bill · checked Oct 1
Check price for SnagRxOn SnagRx's site · partner link
These two prices are different kinds of bill, so read the line under each price before you compare them.
Embody and SnagRx both pay us a commission through our links. They share an operator, but each keeps a separate offer and review record. Commission does not set our scores or this recommendation. How we make money
Start with Embody if you want the smaller verified initial commitment. Its public catalogue lists one-month compounded semaglutide at $79 and tirzepatide at $129. SnagRx lists $99 and $149 month to month; its $69 and $119 floors require twelve months paid up front at $828 or $1,428. Embody's yearly-plan sale, advertised October 27 through December 1, 2026, was $588 or $1,188 prepaid, equivalent to $49 or $99 per month. Confirm current and renewal terms. Both storefronts are operated by Modern Metabolic Medicine, Inc., use OpenLoop Health and name the same four pharmacies. Neither public record establishes a clinical-quality advantage.
Our pick for the smaller verified initial commitment
Embody's catalogue lists one-month compounded semaglutide at $79 and tirzepatide at $129, with care and shipping included.
Its yearly-plan sale, advertised October 27 through December 1, 2026, required $588 or $1,188 prepaid, equivalent to $49 or $99/month. Confirm current and renewal terms.
Consider SnagRx if you prefer its published term-by-term grid
SnagRx shows the amount billed for one, three, six and twelve months before intake and names the same four partner pharmacies as Embody.
Its $69 semaglutide and $119 tirzepatide rates require $828 or $1,428 paid up front. Multi-month purchases are normally non-refundable.
Sources: Embody current product catalogue · SnagRx pricing and billing terms
| Embody | SnagRx | |
|---|---|---|
| Price | from $49/mo | $99/moBilled monthly; prescription/pharmacy charges may vary |
| Medicine | BothCompounded only | |
| Needle-free option | BothNot listed | |
| Insurance | BothNo insurance listed | |
| Consultation | Included | Evaluation is advertised as included in the program price |
| Shipping | Free | Free, 1-2 day delivery |
| Where it ships | 49 states plus DC, all except Louisiana | The homepage excludes Louisiana and limits Nebraska to patients 19 and over |
| Trustpilot | 3.8 / 5 across 10,100 reviews | 3.2 / 5 across 10 reviews |
| BBB rating | D+ (not accredited) | D+ (not accredited) |
| Our score | 7.6/10 Good | 6.7/10 Fair |
| Assessment limits | Checked Oct 16, 2026; a rating claim didn't match Trustpilot. | Checked Oct 16, 2026; few independent reviews yet. |
Four published plan lengths for each injection. A sale advertised October 27 through December 1, 2026 cut the twelve-month prepaid amounts to $588 for semaglutide and $1,188 for tirzepatide; one-month plans stayed at $79 and $129.
Payments are normally non-refundable; a limited medical-disqualification exception applies.
The October 27–December 1, 2026 sale offers semaglutide at $49/month equivalent ($588 prepaid for twelve months) and tirzepatide at $99/month equivalent ($1,188 prepaid). One-month plans remain $79 and $129. The published terms say the rate stays fixed on the selected plan. Confirm the renewal amount and date before paying; these sale rates are not month-to-month bills.
We checked Embody's prices on October 27, 2026.Every Embody price and plan
Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.
Want Embody on its own? Read our Embody GLP-1 review to see what you pay for semaglutide or tirzepatide and what customer reviews say, or check is Embody legit for its BBB, Trustpilot and FDA records.
Published semaglutide price: $99/mo billed monthly, or $69/mo with $828 paid upfront for 12 months. Evaluation, medication, support and shipping are advertised as included. Confirm the full bill at checkout, because the terms let medication and pharmacy prices vary. Same operator as Embody.
We checked SnagRx's prices on October 1, 2026.
Embody's public catalogue lists compounded semaglutide at $79 for one month and tirzepatide at $129. On October 27 it also listed twelve-month plans at $588 and $1,188, equal to $49 and $99 per month, in a yearly-plan sale advertised through December 1, 2026. Confirm any current twelve-month price, the renewal amount and its date before paying.
SnagRx lists semaglutide at $99 month to month, $267 for three months, $474 for six months and $828 for twelve months. Its tirzepatide terms list $149 month to month, $417 for three months, $774 for six months and $1,428 for twelve months. Multi-month plans are billed once up front and renew for the same length unless cancelled.
The practical difference is the first charge. Embody's verified one-month catalogue prices are $20 lower for either molecule. During its yearly-plan sale advertised October 27 through December 1, 2026, Embody cost $588 for semaglutide or $1,188 for tirzepatide prepaid, $240 less than SnagRx's respective $828 and $1,428 twelve-month totals.
Sources:Embody catalogue and term totals· Embody promotional offer· SnagRx plan totals and renewal terms· Complete Embody review· Complete SnagRx review
Modern Metabolic Medicine, Inc. operates both storefronts. Their current public records name OpenLoop Health as the clinical network and the same four 503A pharmacy partners: Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx. Neither storefront says which pharmacy will fill an individual prescription before approval.
They remain separate shopping surfaces with different plan displays, checkout paths, terms and Trustpilot profiles. Sharing an operator does not mean a prescription, dose, pharmacy assignment or service outcome will be identical. It does mean that choosing between them is mainly a question of commitment, checkout clarity and storefront-specific evidence rather than choosing between two unrelated medical organizations.
Both menus concern compounded semaglutide and tirzepatide injections. Compounded drugs are not FDA approved, and FDA does not review them for safety, effectiveness or quality before marketing. Public pages do not establish that one storefront's compounded medication is safer or more effective than the other's.
Sources:Embody terms and operating entity· SnagRx terms and operating entity· FDA questions and answers on compounding
Both refund policies say payments are normally final and non-refundable at purchase. Cancelling stops a future renewal but does not return money already paid. Both policies describe a limited provider-initiated medical-disqualification exception, with services already provided deducted from any refund. A twelve-month plan is therefore a committed purchase, not twelve freely cancellable monthly payments.
The storefront-specific review samples are not comparable in size. Embody showed 3.8/5 across 10,100 Trustpilot reviews on October 17, 2026, including reviews merged from another profile. SnagRx showed 3.2/5 from 10 reviews on October 16, which is too few reviews to rate. Neither rating proves clinical quality.
The BBB profile belongs to Modern Metabolic Medicine, Inc., not one storefront. It showed D+, not accredited, with 245 company-wide complaints on October 17, 2026 and listed Embody, SnagRx and RodeoMeds as alternate names. The total includes cases with different outcomes. Individual brand context is needed before assigning a complaint to either storefront.
Sources:Embody refund and cancellation policy· SnagRx refund and cancellation policy· Embody on Trustpilot· SnagRx on Trustpilot· Shared operator at the BBB
Strengths
More to watch for
Strengths
More to watch for
Compounded medicines are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are sold. Read the FDA's explanation of the risks.
Yes.
Embody has the lower verified one-month catalogue prices: $79 for compounded semaglutide and $129 for tirzepatide, compared with SnagRx at $99 and $149.
Neither current public catalogue lists brand-name Wegovy or Zepbound.
Cancelling either service can stop a future renewal, but both policies normally make amounts already paid non-refundable.
Start with Embody if a lower one-month commitment matters.
Embody:prices checked October 27, 2026, score evidence assessed October 16, 2026.Read our Embody review
SnagRx:prices checked October 1, 2026, score evidence assessed October 16, 2026.Read our SnagRx review
We score on a published methodology, and partnership never changes a score or a fact here.
Before you sign up, read our trust checks: is Embody legit and is SnagRx legit.